Sources | Names Used |
---|---|
CTRPv2 | Compound 1541A |
PharmacoGx | Compound 1541A |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HMGB3 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.05 |
mRNA | GPRC5A | CTRPv2 | pan-cancer | AAC | -0.087 | 0.05 |
mRNA | RP4-614O4.11 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.05 |
mRNA | NUTM2E | CTRPv2 | pan-cancer | AAC | 0.077 | 0.05 |
mRNA | PODXL2 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.05 |
mRNA | S100A10 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.05 |
mRNA | SLC2A7 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
mRNA | ATP10B | CTRPv2 | pan-cancer | AAC | 0.082 | 0.05 |
mRNA | URB1 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.05 |
mRNA | QRFP | CTRPv2 | pan-cancer | AAC | 0.077 | 0.05 |